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Effect of dietary intervention on serum lignan
levels in pregnant women - a controlled trial
Riitta Luoto1,7*, Elham Kharazmi2, Niina M Saarinen3, Annika I Smeds4, Sari Mäkelä3, Mahdi Fallah2, Jani Raitanen1,5,
Leena Hilakivi-Clarke6
Abstract
Background: Mother’s diet during pregnancy is important, since plant lignans and their metabolites, converted by
the intestinal microflora to enterolignans, are proposed to possess multiple health benefits. Aim of our study was
to investigate whether a dietary intervention affects lignan concentrations in the serum of pregnant women.
Methods: A controlled dietary intervention trial including 105 first-time pregnant women was conducted in three
intervention and three control maternity health clinics. The intervention included individual counseling on diet and
on physical activity, while the controls received conventional care. Blood samples were collected on gestation
weeks 8-9 (baseline) and 36-37 (end of intervention). The serum levels of the plant lignans 7-hydroxymatairesinol,
secoisolariciresinol, matairesinol, lariciresinol, cyclolariciresinol, and pinoresinol, and of the enterolignans 7-
hydroxyenterolactone, enterodiol, and enterolactone, were measured using a validated method.
Results: The baseline levels of enterolactone, enterodiol and the sum of lignans were higher in the control group,
whereas at the end of the trial their levels were higher in the intervention group. The adjusted mean differences
between the baseline and end of the intervention for enterolactone and the total lignan intake were 1.6 ng/ml (p
= 0.018, 95% CI 1.1-2.3) and 1.4 ng/mg (p = 0.08, 95% CI 1.0-1.9) higher in the intervention group than in the
controls. Further adjustment for dietary components did not change these associations.
Conclusion: The dietary intervention was successful in increasing the intake of lignan-rich food products, the fiber
consumption and consequently the plasma levels of lignans in pregnant women.
Trial registration: ISRCTN21512277, http://www.isrctn.org
Introduction
During pregnancy, the fetus is exposed to multiple bio-
logically active compounds that originate from the
maternal diet. Some of these may affect offspring’s later
health. Dietary phytoestrogens are examples of such
compounds, as they are found in the amniotic fluid and
the umbilical cord blood [1]. In the Western diet, phy-
toestrogens consist mainly of plant lignans, which are a
large group of fiber-associated phenolic compounds,
widely distributed in edible plants, e.g., seeds, whole
grains, vegetables, fruits and berries [2,3]. Significant
dietary sources of fiber-associated phenolic compounds
are beverages such as coffee, tea, and red wine [2,3].
Many of the ingested plant lignans in food are converted
by intestinal microbiota to enterolignans, e.g., enterodiol
(ED) and enterolactone (ENL) [4]. Enterolignans
undergo enterohepatic circulation [5] and are thereafter
found in a number of tissues [6].
Dietary lignans have been portrayed as health-promot-
ing agents in many epidemiological studies, which show
an inverse association between plant lignan intake or
serum/urine enterolignan concentrations and chronic
Western life-style diseases, including breast and colon
cancer, and cardiovascular diseases [7]. Furthermore,
chemopreventive actions of lignans against mammary
cancer have been demonstrated in experimental models
[8,9]. They are potentially mediated through mechan-
isms such as modulation of estrogen action and by pos-
sessing anti-angiogenic, pro-apoptotic, and anti-oxidant
properties [9].
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Several studies indicate that supplementation of a
habitual diet with lignan-rich foods can affect circulating
enterolignan concentrations in women [7]. However,
there are only scarce data available on serum lignan
concentrations of pregnant women [10,11], and there
are no studies available that have investigated whether a
dietary intervention towards “a healthier diet” through
dietary counselling would influence enterolignans and
other commonly occurring plant lignans in pregnant
mothers. Main aim of the intervention study was to find
out, whether counselling on physical activity, diet and
weight development have effect on pregnancy weight
development [12,13]. The goal of dietary counseling was
to modify the diet of first-time pregnant women accord-
ing to the current nutritional recommendations. Aim of
this study is to report changes in lignan concentrations
among experimental groups. To our knowledge, this is
the first study to determine whether changes in the
habitual diet can affect serum lignan concentrations of
pregnant women.
Methods
Setting and study design
Each municipality in Finland is responsible for arranging
maternity health-care services for its residents, and
these are covered by public tax revenue. Almost all
(99.7%) pregnant women attend public maternity clinics
[14]. The present study was conducted at six volunteer-
ing clinics in the city of Tampere and the town of
Hämeenlinna, both located in the southern Finland. The
study was approved by the Ethics Committee of the Pir-
kanmaa Hospital District. A flow chart of the study is
shown in additional files, additional file 1.
In the Finnish maternity health-care system, pregnant
women are recommended to visit 11-15 times a nurse
and three times to a physician. This study was imple-
mented during two of these routine visits to nurses at
gestation weeks 8-9 (baseline) and 36-37 (end of
intervention).
Participants
The participants were pregnant women with no earlier
deliveries. Women who were younger than 18 years of
age, or suffered from type I or type II diabetes mellitus,
twin pregnancy, physical disability that prevented exer-
cising or had otherwise problematic pregnancy, sub-
stance abuse, treatment or clinical history of any
psychiatric illness, were unable to speak Finnish, or
intended to change residence within three months, were
excluded from the study. The nurses recruited the parti-
cipants when they enrolled for their first clinic visit at
the beginning of their pregnancy, usually by phone.
Forty-nine women in the intervention clinics and 56
women in the control clinics gave informed consent for
participation. Recruitment took place between August
2004 and January 2005.
The participants visiting the control clinics received
the standard maternity care. The intervention group
received recommendations for gestational weight gain
and physical activity counseling, the details of which are
presented elsewhere [12,13].
For the dietary counseling, the following dietary objec-
tives were set for each participant to achieve or main-
tain: 1) to follow a regular meal pattern, emphasizing
the importance of breakfast and > = 1 hot meal every
day, 2) to eat at least five portions (400 g) per day, in
total, of different kinds of vegetables, fruits and berries,
3) to consume preferentially high-fibre bread (> = 5 g
fibre/100 g), and 4) to restrict the intake of high-sugar
snacks to < = 1 portion per day (e.g., 50 g sweets, one
pastry, once piece of cake, two biscuits, 2 dl of ice
cream or a glass of soft drink). The dietary counselling
consisted of one primary counselling session (allocated
time 20-30 min) at the visit during gestation weeks 16-
18, and three booster sessions (allocated time 10 min)
until gestation week 37.
Data collection
The pre-pregnancy weight and height were self-
reported, whereas weight development during the preg-
nancy was based on measurement by nurses in mater-
nity centers. The baseline questionnaire, including
questions on background, lifestyle and dietary intake (a
57-item food frequency questionnaire), was completed
before the first visit (at gestation week 8 or 9). The sec-
ond follow-up questionnaire was completed at the end
of the study, on gestation week 37. Similar FFQ was
filled by both groups. The baseline dietary information
was based on the diet during the month before the
pregnancy and the follow-up information on the diet
during the month before the 26 to 28 pregnancy week’s
visit.
Lignan measurements
The plant lignans 7-hydroxymatairesinol, secoisolaricire-
sinol, matairesinol, lariciresinol, cyclolariciresinol, and
pinoresinol, and the enterolignans 7-hydroxyenterolac-
tone, enterodiol, and enterolactone were quantified in
the serum using a previously developed and validated
high-performance liquid chromatography-tandem mass
spectrometric (HPLC-MS/MS) method [15]. Briefly, the
method included enzymatic hydrolysis, solid-phase
extraction, and analysis using a triple quadrupole mass
spectrometer with electrospray ionisation in the multi-
ple-reaction monitoring mode. The serum lignans were
quantified using deuterated matairesinol or enterolac-
tone as internal standards. Pinoresinol, which was not
included in the validated method, was added among the
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analytes. The MS/MS transition monitored for this com-
pound was the deprotonated molecular ion to the pre-
dominant fragment ion of m/z 151, and deuterated
matairesinol was used as internal standard.
Statistical methods
Baseline information on age, pre-pregnancy BMI, weight
gain during pregnancy, education level and smoking sta-
tus before and during pregnancy were reported by both
in the intervention and the control groups. Education
was self-reported and categorized as basic or secondary
education, polytechnic or university training. Smoking
was inquired both before (non-smokers or quitters; daily
or occasional smokers) and during pregnancy (occa-
sional smoking or non-smoking). These variables were
later included, when necessary, as confounding factors
in the multivariable analyses. In all statistical analyses, p
< 0.05 was used as the level of statistical significance.
The group differences of lignans at the end point of
both follow-ups adjusted for the baseline level of lignans
and other possible confounders were examined by the
linear regression model. The original lignan values were
skewed, and were transformed by using the logarithm to
enable statistical analysis requiring normally distributed
variables. The results at the end point of each follow-up
are illustrated as a group difference calculated using
antilogs of mean differences of log-transformed vari-
ables, and presented with 95% CI.
In the regression model, the analyses included baseline
level of lignans, age, BMI, education, smoking and
change in consumption of vegetables and fruits. Further
adjustment was performed for dietary components that
affect lignan intake or are thought to intervene with lig-
nan metabolism. These were coffee, tea, other drinks,
butter, potato, peas, milk products, pork, beef, and
sugar. Since these dietary variables were not significant,
they were dropped out from the backward stepwise
regression model.
Results
Women in the intervention group were younger, less
educated, and were more often smokers, and they had a
higher pre-pregnancy weight and BMI on average than
the women in the control group (Table 1).
Enterolactone was detectable in almost all the samples
(Table 2). Other lignans, such as hydoxyenterolactone,
matairesinol, and lariciresinol were detected only in very
few women. Among the women in the intervention
group, the concentration of almost all serum lignans
increased during intervention, while among the controls
the serum concentrations of lignans other than entero-
lactone either did not change or they were reduced. The
baseline levels of enterolactone, enterodiol and the sum
of the lignans were higher in the control group than in
the intervention group. However, as a result of the
intervention, the levels of lignans in the intervention
group increased to a significantly higher level than
among the controls (Table 2).
Group differences were analyzed taking into account
baseline lignans, age, BMI, education and smoking. The
adjusted mean difference for enterolactone at the end of
the intervention when compared to the baseline was 1.6
ng/ml higher in the intervention group than in the con-
trols (p = 0.018; 95% CI: 1.1-2.3, adjusted for lignan at
baseline, age, BMI, education and smoking). Similar
results were found for enterolignan (P = 0.021; 95% CI:
1.1-2.2). The mean adjusted difference between baseline
and end for the sum of lignans was 1.4 ng/ml (P =
0.083; 95% CI: 1.0-1.9) higher in intervention group
than in the controls (Table 3). Group differences were
additionally analyzed by including change in consump-
tion of vegetables and fruits, meat, and bread in the
backward stepwise selection regression model. Only the
baseline level of enterolignans, the change in vegetable
and fruit consumption, and education were significantly
correlated with the group differences (Table 3).
Discussion
The results obtained in our controlled trial involving
pregnant women indicate that the serum levels of enter-
olignans at the end of the intervention period were sig-
nificantly higher in the intervention group than in the
controls. This is consistent with our earlier results
showing that intake of vegetables, fruits, berries and
fiber - all of which contain lignans - is significantly
higher in the pregnant intervention group than in the
controls [16].
Strengths of our study include experimental, con-
trolled design and exact measurements of lignans based
on blood samples and nutrition based on large food fre-
quency questionnaires. Other strengths of the study
were that the participation rate to the intervention was
excellent, as only a few visits were missed [13]. To date,
similar findings have not been reported in any experi-
mental study among pregnant women and thus our
findings are unique.
The concentrations of enterolactone in serum are
associated with consumption of lignan-containing foods
and constipation [17], and urinary lignan excretion is
positively associated with dietary fiber intake, as well as
with diets that are high in fiber and carbohydrates and
lower in fat. Coffee and tea also affect plasma concen-
trations of enterolactone [18]. Our results show that the
baseline (pregnancy weeks 8-9) consumption of lignan-
rich ingredients, such as vegetables and fruits, and the
level of education are the main confounders on the
adjusted mean difference in enterolactone levels. Well-
educated individuals are known to consume more fruits,
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Table 1 Background variables in control and intervention groups
Control Intervention Control Intervention
Characteristic N N mean SD mean SD P-value
Pre-pregnancy age 56 49 28.8 4.1 27.4 4.6 0.1051
Pre-pregnancy BMI 56 49 22.3 2.1 23.6 4.0 0.0361
Change in fiber (g/day) 53 49 -0.2 6.3 2.7 6.5 0.02161
Smoking during pregnancy % % 0.2602
Occasionally 3 0 3.1 0.0
Not at all 53 41 54.6 42.3
Pre-pregnancy smoking % % 0.0653
Non-smoker/quitted 46 32 45.1 31.4
Daily/occasionally 9 15 8.8 14.7
Education % % 0.0623
Basic/secondary level 20 27 19.4 26.4
Polytechnic school 12 9 11.8 8.9
University 24 11 23.7 10.9
1) T-test
2) Fisher’s Exact Test
3) Chi-square
Table 2 Percentiles (%) of women exhibiting different lignans, average concentrations and concentration range (ng/
ml) of individual lignans in the control and intervention groups at the baseline and at the end of intervention.
Baseline (gestational week 8 or 9) End (gestational week 36 or 37)
Control* Detected in number (%) of
samples
Mean ng/ml
(SD)
Range
(nd = not
detected)
Positive
samples
Mean ng/ml
(SD)
Range
ENL 53 0.46 (0.68) nd-4.4 52 0.48 (0.38) 0.03-2.4
HENL 14 0.03 (0.024) nd-0.09 17 0.02 (0.05) 0-0.18
SECO 4 0.22 (0.077) 0.15-0.33 12 0.12 (0.09) 0-0.3
MR 39 0.003 (0.01) nd-0.07 49 0.003 (0.01) 0-0.05
END 28 0.22 (0.34) nd-1.8 32 0.22 (0.31) 0-1.45
LAR 9 0.14 (0.1) nd-0.29 3 0.01 (0.02) 0-0.04
CLAR 10 0.13 (0.23) nd-0.58 15 0.14 (0.12) 0-0.43
PINO 1 0.58 (0) 0.58-0.58 4 0.25 (0.27) 0-0.61
Sum of all
lignans
56 0.63 (0.82) nd-4.61 56 0.66 (0.65) 0-3.48
Intervention*
ENL 49 0.34 (0.39) nd-2.2 49 0.85 (1.4) 0.09-7.4
HENL 10 0.03 (0.02) nd-0.064 15 0 0
SECO 2 0.10 (0.09) 0.04-0.17 10 0.16 (0.15) 0.015-
0.5
MR 33 0.004 (0.02) nd-0.13 45 0.004 (0.01) 0-0.07
END 32 0.12 (0.12) nd-0.33 32 0.19 (0.20) 0-0.82
LAR 7 0.03 (0.05) nd-0.11 2 0.05 (0.07) 0-0.1
CLAR 9 0.10 (0.16) nd-0.48 9 0.04 (0.07) 0-0.2
PINO 3 0.58 (0.26) 0.30-0.81 4 0.21 (0.15) 0-0.33
Sum of all
lignans
49 0.49(0.48) 0.01-2.25 49 1.03 (1.56) 0.14-
8.16
*ENL = enterolactone, HENL = 7-hydroxyenterolactone, SECO = secoisolariciresinol, MR = matairesinol, END = enterodiol, LAR = lariciresinol, CLAR =
cyclolariciresinol, PINO = pinoresinol
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vegetables and fiber than less educated individuals [19],
and this likely caused the association between education
and enterolactone levels during pregnancy observed in
this study. However, dietary intake or education
appeared to explain only a small proportion of our
results. The role of gut microflora in the metabolism of
lignans is known to be important, and future studies are
needed to determine the bioavailability and absorption
rate of lignans in pregnant women consuming diets high
in vegetables, fruits and fiber.
The results reported here are based on a pilot study
designed to test the intervention protocol for a larger
study. The lack of randomization of the maternity
clinics was probably the most important limitation of
the present study. The baseline differences in several
factors between the intervention and control groups
might have been smaller had we been able to randomize
the clinics. On the other hand, the women themselves
do not make choices between clinics, because they are
directed to maternal centers based on their living area.
Thus, non-randomization is not as large bias as in the
case of randomization by patient basis, not by clusters
(maternity centers).
The intervention group was less educated than the con-
trol group. Education is widely known to be associated
with diet and BMI [19] and may affect the effect of inter-
vention. Pre-pregnancy BMI, smoking status and educa-
tion were taken into account in the analyses, but the
baseline differences in these variables between the groups
may have contributed to the efficacy of the intervention.
An important factor is the use of antibiotics, which
affects the bacterial flora of the intestine, and therefore
the level of lignans in circulation. In our study, there
were only a few pregnant women who reported the use
of antibiotics, and thus, their use may not have played
any significant role. Another factor which may have influ-
enced the finding, is that the control group received diet-
ary and physical activity counseling as a part of the
standard maternity care, although not at the same level
of intensity as the women in the intervention group.
Awareness of being in a trial may have influenced the
counseling practices of the control nurses, as well as the
health behavior of the control women.
The small sample size was also a limitation of this
study. Due to the small number of clinics, the clinic-
level variation could not be taken into account by using
multilevel analysis. Furthermore, there were more drop-
outs in the intervention group than in the control
group. Although the drop-out reasons were only partly
related to the study, the drop-outs might have been less
motivated to change their health behavior. In this pilot
study, information on diet was obtained by question-
naires, which have not been validated for pregnant
women. Additionally, use of food frequency question-
naire may be a limitation since the groups are not
directly comparable. Weight before the pregnancy was
self-reported, which may induce some bias. However,
weight development during the pregnancy was measured
by the nurses, and thus more reliably collected.
The pregnant women in this study were healthy pri-
miparas, who had relatively healthy dietary and physical
activity habits. Therefore, there may not have been
much room to further improve their diet. However,
changes were noticed on diet and serum lignan levels
among the women in the intervention group, indicating
that the dietary intervention was successful.
It is essential to determine whether this pregnancy
intervention has any impact on the offspring’s health. In
our previous study, none of the newborns in the inter-
vention group had a high birthweight [16] - an indicator
of increased susceptibility to obesity and breast cancer,
suggesting that increasing dietary intake of fruits, vege-
tables and fiber benefits the offspring.
We have shown earlier by using animal models that
changes in maternal diet during pregnancy alter mam-
mary cancer risk among female offspring [20,21]. Other
investigators have reported increased susceptibility to
cardiovascular diseases, type 2 diabetes and other
adverse health effects in animal models and humans
caused by insufficient energy or protein intake during
pregnancy [22]. Although we generally associate lignan
intake to positive health outcomes [7], nothing is known
Table 3 Group differences between enterolactone, enterolignan and the sum of lignans (ng/ml) at the end of the
intervention*.
Enterolactone Enterolignan Sum of lignans
coeff p 95% CI coeff p 95% CI coeff p 95% CI
Intervention vs control, 1.6 0.018 1.1-2.3 1.5 0.02 1.1-2.2 1.4 0.08 1.0-1.9
Lignans, baseline 1.61 0.01 1.16-2.24 1.42 0.00 1.26-1.60 1.29 0.04 1.01-1.29
Change in consumption of vegetables and fruits 1.14 0.04 1.01-1.30 1.53 0.02 1.08-2.16 1.14 0.03 1.01-1.14
University vs. basic/secondary school 1.83 0.01 1.20-2.81 1.62 0.02 1.09-2.41 1.81 0.00 1.23-1.81
Polytechnic vs. basic or secondary school 2.37 0.00 1.45-3.89 0.37 0.00 0.27-0.50 2.41 0.00 1.54-2.41
*All results in the table have been adjusted for baseline level of lignans, age, BMI, education, smoking, change in consumption of vegetables and fruits.
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of their effects on the offspring exposed through a preg-
nant mother. A recent study in rats indicating that an
exposure to multivitamins during pregnancy accelerated
the development of obesity among offspring [23] raises
concerns regarding the safety of pregnancy supplemen-
tations. However, there is no evidence that high dietary
intake of fruits, vegetables and fiber during pregnancy
has any adverse effects on the health of the offspring.
Future studies should increase understanding of lignan
effects to offspring.
Additional material
Additional file 1: Flow chart of the trial. Flow chart of the cluster-
randomized trial showing participating clinics, number of women
eligible, randomized and drop-outs.
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